What You Need to Know Before Meeting Potential Users of Your Technology
September 13, 2007
Prior to engaging in discussions with potential users of your nutraceutical technology, you need to have such persons or entities execute proper confidentiality, non-disclosure, non-circumvention, and non-solicitation agreements in order to adequately protect your company and its technology. In his byline on www.nutraingredients-usa.com, Foley’s Thomas James discusses the various types of documents that are vital to a nutraceutical company’s protection and the importance of executing them prior to your first meeting.
Click here for the full article.
Related Insights
March 12, 2026
Foley Viewpoints
What To Do If You Receive an NAIC AI Systems Evaluation Tool Pilot Request
Summary & Takeaways: The NAIC’s AI Systems Evaluation Tool Pilot Project has begun generating domiciliary regulator requests for…
March 12, 2026
Health Care Law Today
GLP‑1 Compliance: FDA Targets Telehealth Marketing in 30 New Warning Letters
On March 3, 2026, U.S. Food & Drug Administration (FDA) sent 30 warning letters to telehealth companies that market compounded GLP‑1…
March 11, 2026
Tariff & International Trade Resource
What Every Multinational Should Know About…Managing the Aftermath of the Supreme Court’s IEEPA Tariff Decision (Part III)
The importer of record is the entity that initially pays all tariffs and thus is the entity that would receive any IEEPA tariff refunds. Nonetheless, behind the scenes there often are a variety of mechanisms importers of record may have used to handle the often unexpected tariffs, including pushing back on suppliers for price concessions, using surcharges to pass along tariffs, or generally increasing price. In many cases, other parties may be looking to share any potential refunds.